(Q34291982)

1 August 2017

1 reference

title

KSHV/HHV8-associated lymphoproliferations in the AIDS setting (English)

1 reference

1 August 2017

Schulz TF

1

1 reference

1 August 2017

1 July 2001

1 reference

European Journal of Cancer

1 August 2017

1 reference

1 August 2017

37

1 reference

1 August 2017

1217-1226

1 reference

1 August 2017

10

1 reference

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human immunodeficiency virus-associated malignant lymphoma in eastern Denmark diagnosed from 1990-1996: clinical features, histopathology, and association with Epstein-Barr virus and human herpesvirus-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

HHV-8 in lymphoproliferative lesions in skin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kaposi's Sarcoma-Associated Herpesvirus Infection and Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

HHV-8 and multiple myeloma in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Dendritic cells derived from bone marrow and CD34+selected blood progenitor cells of myeloma patients, cultured in serum-free media, do not contain the Kaposi sarcoma herpesvirus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

CD138-positive and Kaposi's sarcoma-associated herpesvirus (KSHV)-negative B-cell lymphoma with serosal spreading of the body cavity and lymphadenopathy: an autopsy case

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations ofBCL6: Implications for disease pathogenesis and histogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Proliferation in HHV-8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human herpes virus 8 interleukin-6 homologue triggers gp130 on neuronal and hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

The role of human herpesvirus 8 and Epstein-Barr virus in the pathogenesis of giant lymph node hyperplasia (Castleman's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kaposi's sarcoma-associated herpesvirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

p53 inhibition by the LANA protein of KSHV protects against cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Cyclin encoded by KS herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

Lack of evidence of HHV-8 in mature T-cell lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900115-0

7 January 2021

10.1016/S0959-8049(01)00115-0

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11423254